[Progress on the studies of cyclic lipopeptides].
Cyclic lipopeptide, also named as acylpeptide, which was characteristic with novel structures, was paid more attention in the recent years. Cyclic lipopeptide showed various bioactivities including antibacterial, anti-tumor, anti-inflammatory, etc. Cyclic lipopeptide originated mainly from the second metabolites of microorganism, such as Cyanobacterium, Bacterium, Actinomyces, etc. The bacteria included the genus of Bacillus and Pseudomonas. In this account, the review has been made on the development of cyclic lipopeptide.
Tang
Jin-shan
JS
School of Traditional Chinese Materia Medica, Shenyang Pharmnaceutical University, Shenyang 110016, China.
Gao
Hao
H
Dai
Yi
Y
Hong
Kui
K
Yao
Xin-sheng
XS
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D001407:Bacillus / Q000737:chemistry*; D000458:Cyanobacteria / Q000737:chemistry*; D017576:Daptomycin / Q000302:isolation & purification / Q000494:pharmacology; D006801:Humans; D055666:Lipopeptides / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D010456:Peptides, Cyclic / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D011549:Pseudomonas / Q000737:chemistry*
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; C503384:Laxaphycin B; D055666:Lipopeptides; D010456:Peptides, Cyclic; C009365:surfactin peptide; D017576:Daptomycin